<TEXT>&#2;<DATELINE>2019-12-15</DATELINE><TITLE>Is Oral Ribavirin for the Treatment of Respiratory Syncytial Virus in High-risk Hematopoietic Stem Cell Transplant Recipients Really Safe?</TITLE><BODY>&#3;</BODY></TEXT>